This interpretation is supported by the recent study of Cecerska-Heryć et al., who reported that COVID-19 is associated with a marked decrease in reduced GSH and disruption of redox homeostasis, accompanied by increased activities of GR and glutathione S-transferase (GST). Here, HPGDS is linked to COVID-19.